Warning: Creating default object from empty value in /customers/4/c/6/biochronicles.net/httpd.www/wp-content/plugins/widgetize-pages-light/include/otw_labels/otw_sbm_grid_manager_object.labels.php on line 2 Warning: Creating default object from empty value in /customers/4/c/6/biochronicles.net/httpd.www/wp-content/plugins/widgetize-pages-light/include/otw_labels/otw_sbm_shortcode_object.labels.php on line 2 Warning: Creating default object from empty value in /customers/4/c/6/biochronicles.net/httpd.www/wp-content/plugins/widgetize-pages-light/include/otw_labels/otw_sbm_factory_object.labels.php on line 2 bambini bolla | BioChronicles
Menu
terapia genica

Terapia genica: una nuova speranza chiamata Strimvelis.

GlaxoSmithKline (GSK), Fondazione Telethon (Telethon), l’IRCCS Ospedale San Raffaele (OSR) confermano l’autorizzazione da parte della Commissione Europea alla commercializzazione di Strimvelis, la prima terapia genica ex-vivo con cellule staminali capace di trattare i pazienti affetti da una rarissima malattia chiamata ADA-SCID (immunodeficienza severa combinata da deficit di adenosina-deaminasi)

read more
Showing the single result
  TOP